GMAB

GENMAB A/S

SEC CIK 1434265
$25.05 −21.5% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
11
Most recent
Advertisement

At a glance

Insiders at GMAB have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Most active filer: Genmab A/s, with 11 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for GMAB, newest first
View on SEC EDGAR ↗
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 30, 2025 ΔOwn +1.4%

Genmab A/s, MRUS's 10% owner, spent $102.12M of their own money on 1.05M shares at $97, growing their stake 1%.

+$102.12M
1.05M sh @ $97
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 30, 2025 ΔOwn −100%
−$7.36B
75.87M sh @ $97
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 30, 2025

Genmab A/s, MRUS's 10% owner, spent $288.9K of their own money on 2,978 shares at $97.

+$288.9K
2,978 sh @ $97
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 29, 2025 ΔOwn +0.2%

Genmab A/s, MRUS's 10% owner, spent $13.83M of their own money on 142,610 shares at $97.

+$13.83M
142,610 sh @ $97
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 29, 2025 ΔOwn +0.1%

Genmab A/s, MRUS's 10% owner, spent $9.32M of their own money on 96,082 shares at $97.

+$9.32M
96,082 sh @ $97
Advertisement
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 29, 2025 ΔOwn +0.8%

Genmab A/s, MRUS's 10% owner, spent $54.42M of their own money on 561,042 shares at $97, growing their stake 1%.

+$54.42M
561,042 sh @ $97
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 29, 2025

Genmab A/s, MRUS's 10% owner, spent $1.52M of their own money on 15,710 shares at $97.

+$1.52M
15,710 sh @ $97
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 22, 2025 ΔOwn +0.1%

Genmab A/s, MRUS's 10% owner, spent $6.43M of their own money on 66,264 shares at $97.

+$6.43M
66,264 sh @ $97
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 22, 2025 ΔOwn +0.3%

Genmab A/s, MRUS's 10% owner, spent $20.58M of their own money on 212,177 shares at $97.

+$20.58M
212,177 sh @ $97
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 18, 2025 ΔOwn +0.2%

Genmab A/s, MRUS's 10% owner, spent $14.63M of their own money on 150,795 shares at $97.

+$14.63M
150,795 sh @ $97
MRUS
Buy GENMAB A/S · 10% Owner · Open-market purchase · filed Dec 18, 2025 ΔOwn +0.2%

Genmab A/s, MRUS's 10% owner, spent $11.71M of their own money on 120,752 shares at $97.

+$11.71M
120,752 sh @ $97
Advertisement

About GMAB insider activity

This page tracks every recent Form 4 filed for GENMAB A/S with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is GMAB insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for GENMAB A/S usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.